Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 5/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 0||UN / UN|
Administered by: Unknown Purchased by: Unknown
Symptoms: Chronic fatigue syndrome, Malaise, Paralysis, Photophobia
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Diagnostic Lab Data:
CDC 'Split Type': NO0095075131701NOR001401
Write-up:Information was received from regulatory authority (agency# NO-NOMAADVRE-FHI-2016-23150) via SPMSD on 29-DEC-2016. This spontaneous report as received from an other health professional refers to a 14 year old female patient. On 26-SEP-2013, the patient was vaccinated with the first dose of GARDASIL dose 0.5 ml, parenterally for prophylaxis. On 12-DEC-2013 and 08-MAY-2014, the patient received the second and the third dose of quadrivalent GARDASIL 0.5 ml parenterally for prophylaxis, respectively. The girl had been very ill in the last one and a half year from about June 2015. On an unknown day in 2015, the patient experienced chronic fatigue syndrome, photophobia and paralysis. The outcome of chronic fatigue syndrome, photophobia and paralysis was reported as not recovered/not resolved. The events: chronic fatigue syndrome, photophobia and paralysis were considered to be serious: disability. The reporter considered chronic fatigue syndrome, photophobia and paralysis to be possibly related to GARDASIL. Agency has requested additional information. This is a preliminary report. Sender''s Comments: First dose Gardasil given 20130926. Second dose Gardasil given 20131212. The girl has been very ill the last one and a half year; from about 201506. Agency has requested additional information. This is a preliminary report.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166